PALISADE BIO, INC. — Director's Dealing 2014

Apr 11, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Neuralstem, Inc. (CUR)
CIK: 0001357459
Period of Report: 2014-04-09

Reporting Person: OGILVIE SCOTT VARDE (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-04-09	Common Stock	M	20000	$3.30	Acquired	35000	Direct
2014-04-09	Common Stock	F	14163	$4.66	Disposed	20837	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-04-09	Common Stock purchase option	$3.30	M	20000	Disposed	2014-04-11	Common Stock (0)	Direct

Footnotes

F1: Represents shares issued/cancelled upon the cashless exercise of 20,000 Common Stock purchase options at a price per share of $3.30 using a fair market value of the Issuer's stock on 4/9/2014 of $4.66.

F2: Represents shares cancelled pursuant to cashless exercise.